{"organizations": [], "uuid": "3446930e8e3f8e4e0224b74712f3298a09fb90aa", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.pharmamedtechbi.com", "main_image": "", "site_section": "http://feeds.feedburner.com/PharmaBiotechFinancing", "section_title": "Pharma/Biotech Financing From Elsevier Business Intelligence", "url": "https://www.pharmamedtechbi.com/deals/201530514?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "country": "IL", "title": "Australia's Benitec nets $12.8mm in US IPO", "performance_score": 0, "site": "pharmamedtechbi.com", "participants_count": 0, "title_full": "Australia's Benitec nets $12.8mm in US IPO", "spam_score": 0.0, "site_type": "news", "published": "2015-08-19T19:29:00.000+03:00", "replies_count": 0, "uuid": "3446930e8e3f8e4e0224b74712f3298a09fb90aa"}, "author": "", "url": "https://www.pharmamedtechbi.com/deals/201530514?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "ord_in_thread": 0, "title": "Australia's Benitec nets $12.8mm in US IPO", "locations": ["US", "Australia"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Australia's Benitec nets $12.8mm in US IPO Deal Date: Aug-01-2015 / Deal # 201530514 Executive Summary \nBenitec Biopharma Ltd. (gene therapy/silencing), a public Australian company since it IPOd there in 1997, netted $12.8mm in its Nasdaq IPO of 1.5mm ADSs (representing 30mm ordinary shares) for $9.21. The number of ADSs sold was much lower than the 5mm initially planned (at $13.06 each). The company later lowered the terms to 1.9mm ADSs at $10. Investors also received five-year warrants to buy 500k ADSs for $5.50.", "external_links": [], "published": "2015-08-19T19:29:00.000+03:00", "crawled": "2015-08-20T18:04:18.336+03:00", "highlightTitle": ""}